Skip to main content
Caplight Logo









株式会社AiCELLEX

株式会社AiCELLEX

Private
HiroshimaHealthcare & Life Scienceshttps://aicellex.co.jp/

Last Round

Grant

Mar 25, 2024

Total Funding Raised

$7,000

Company Overview

株式会社AiCELLEX is a Japanese healthcare technology company that develops a cloud-based AI system, AiCELLEX, for managing and predicting the quality of cultured cells for regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Computer Vision, Quality Management

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

cell culture quality controlAI image analysisregenerative medicinedrug discoveryautomated cell analysisquantitative cell analysispredictive cell analysislab automationcell therapy manufacturingcomputer visionlife sciences SaaSbiotech softwarein-process quality controlnon-destructive testinglife sciences consulting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

株式会社AiCELLEX Comparables

Compare 株式会社AiCELLEX with similar companies based on industry and business-model similarity.

株式会社AiCELLEX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biodock
78%
Nikon
70%
Sartorius Aktiengesellschaft
69%

株式会社AiCELLEX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 25, 2024
AcceleratorAug 1, 2023

株式会社AiCELLEX Investors

Notable investors and investment history

株式会社AiCELLEX investors
InvestorRounds
Hiroshima Unicorn 10Accelerator
公益財団法人 YMFG地域企業助成基金Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 25, 2024

    $7K grant received from YMFG Regional Enterprise Support Fund.

  • Aug 1, 2023

    Received funding from Hiroshima Unicorn 10.

株式会社AiCELLEX Filings

Explore SEC and related filing metadata, where available.

株式会社AiCELLEX filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 株式会社AiCELLEX's valuation, stock price, and market status.

Is 株式会社AiCELLEX a public or private company?

株式会社AiCELLEX is a private company.

What is the current stock price of 株式会社AiCELLEX?

株式会社AiCELLEX is a private company with no public stock price. No recent secondary market data is available.

How much is 株式会社AiCELLEX worth (valuation)?

Valuation information for 株式会社AiCELLEX is not publicly available.

Can I buy 株式会社AiCELLEX stock?

株式会社AiCELLEX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 株式会社AiCELLEX's last funding round?

株式会社AiCELLEX's most recent funding round was Grant on March 25, 2024.

Who are the main investors in 株式会社AiCELLEX?

Key investors in 株式会社AiCELLEX include Hiroshima Unicorn 10, 公益財団法人 YMFG地域企業助成基金.

Will 株式会社AiCELLEX IPO soon?

No public IPO plans have been announced for 株式会社AiCELLEX.

How can I track 株式会社AiCELLEX secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 株式会社AiCELLEX's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHiroshima
Year Founded2017
Last FundingMar 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?